Clinical trial
Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in…
NCT00499668 · Vanderbilt-Ingram Cancer Center, Other · Withdrawn
Key facts
| NCT number | NCT00499668 |
|---|---|
| Title | Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer |
| Official title | A Pilot Study of Aprepitant Versus Ondansetron for the Treatment of Opioid Induced Nausea and Vomiting |
| Lead sponsor | Vanderbilt-Ingram Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Nausea and Vomiting, Solid Tumor |
| Intervention type | Drug |
| Interventions | aprepitant, ondansetron hydrochloride |
| Enrollment | 0 |
| Start date | Aug 1, 2007 |
| Primary completion | Jan 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Jul 11, 2007 |
| Last update posted | Apr 2, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: